Articles

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia; Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania; Philadelphia, PA
Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Pediatric Hematology-Oncology, Boston Children’s Hospital; Boston, MA
Division of Haematology/Oncology, Hospital for Sick Children and the University of Toronto; Toronto, ON
Department of Preventive Medicine, Keck School of Medicine, University of Southern California; Los Angeles, CA
Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia; Philadelphia, PA
Dan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine and Texas Children’s Cancer Center; Houston, TX
Division of Hematology/Oncology/Bone Marrow Transplant, British Columbia Children's Hospital; Vancouver, BC
Division of Hematology/Oncology, CS Mott Children's Hospital; Ann Arbor, MI
Division of Hematology/Oncology, Children’s Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA
Division of Hematology/Oncology, Children’s Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA
Cancer Centre for Children, The Children's Hospital at Westmead; Westmead, NSW
Division of Hematology/Oncology, Seattle Children's Hospital Cancer and Blood Disorders Center; Seattle, WA
Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia; Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania; Philadelphia, PA
Department of Pediatrics, Memorial Sloan Kettering Cancer Center; New York, NY
Division of Hematology/Oncology, Children’s Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA
Division of Hematology/Oncology, Children’s Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA
Division of Hematology/Oncology, Children’s Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California; Los Angeles, CA
Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia; Philadelphia, PA, USA; Perelman School of Medicine at the University of Pennsylvania; Philadelphia, PA
Haematologica Early view Feb 3, 2022 https://doi.org/10.3324/haematol.2021.279520